Mayanskiy Nikolay, Brzhozovskaya Ekaterina, Pushkov Alexander, Strokova Tatiana, Vlasov Nikolay, Surkov Andrej, Gundobina Olga, Savostianov Kirill
Russian Children Clinical Hospital Pirogov Russian National Research Medical University Moscow Russia.
Laboratory department National Medical Research Center for Children's Health Moscow Russia.
JIMD Rep. 2019 Jun 3;48(1):75-82. doi: 10.1002/jmd2.12050. eCollection 2019 Jul.
Laboratory diagnostics of lysosomal acid lipase deficiency (LAL-D), a rare disorder associated with alterations, are based on the evaluation of LAL activity. In dry blood spots (DBS) submitted for LAL-D diagnostics (the screening cohort) over a two-year period or obtained from a cohort of retrospective LAL-D patients, we measured: (1) LAL activity using a two-reaction assay with 4-methylumbelliferone palmitate (4-MU-Palm) and Lalistat-2, a specific LAL inactivator; (2) total lipase (TL) activity by a 1-hour kinetic 4-MU-Palm cleavage reaction (no Lalistat-2). The TL activity was expressed as the area under the kinetic curve after 1 hour (TL-AUC) of the reaction and presented as the median (min-max). LAL activity was reduced in 30/537 individuals from the screening cohort, among which sequencing revealed six patients and one carrier. Overall, 16 (89%) individuals among six novel and 12 retrospective LAL-D patients carried at least one c.894G>A mutation (six were homozygous). The TL-AUC1h in nonLAL-D specimens with normal LAL activity (n = 90) was unambiguously higher (9471 [4015-23 585] RFUh/punch) compared to LAL-D patients, including six new and nine retrospective patients (1810 [357-2608] RFUh/punch). Importantly, in 13/15 examined nonLAL-D specimens with reduced LAL activity the TL-AUC1h was above a threshold of 2652 RFU*h/punch. Applying this threshold, the TL-AUC1h index discriminated all LAL-D patients (100% sensitivity) and 103/105 nonLAL-D specimens (98% specificity). Given that there is no need for Lalistat-2 and two parallel enzymatic reactions in conjunction with high sensitivity and specificity, the kinetic assay seems to be practical for LAL-D screening.
Lysosomal acid lipase deficiency responsible for Wolman disease and cholesterol ester storage disease could be reliably detected using a kinetic assay of total lipase activity with a fluorogenic substrate.
溶酶体酸性脂肪酶缺乏症(LAL-D)是一种与多种改变相关的罕见疾病,其实验室诊断基于对LAL活性的评估。在为期两年提交用于LAL-D诊断的干血斑(DBS)(筛查队列)中,或从一组回顾性LAL-D患者中获取的干血斑中,我们测量了:(1)使用4-甲基伞形酮棕榈酸酯(4-MU-Palm)和特异性LAL灭活剂Lalistat-2的双反应测定法测量LAL活性;(2)通过1小时动力学4-MU-Palm裂解反应(无Lalistat-2)测量总脂肪酶(TL)活性。TL活性表示为反应1小时后动力学曲线下的面积(TL-AUC),并以中位数(最小值-最大值)表示。筛查队列中的537名个体中有30名LAL活性降低,其中测序发现6例患者和1名携带者。总体而言,6例新诊断的LAL-D患者和12例回顾性LAL-D患者中的16名(89%)携带至少一个c.894G>A突变(6例为纯合子)。与LAL-D患者(包括6例新患者和9例回顾性患者,1810 [357-2608] RFUh/打孔)相比,LAL活性正常的非LAL-D标本(n = 90)中的TL-AUC1h明显更高(9471 [4015-23585] RFUh/打孔)。重要的是,在15例检测到的LAL活性降低的非LAL-D标本中,有13例TL-AUC1h高于2652 RFU*h/打孔的阈值。应用该阈值,TL-AUC1h指数可区分所有LAL-D患者(100%敏感性)和105例非LAL-D标本中的103例(98%特异性)。鉴于不需要Lalistat-2以及两个平行的酶促反应,且具有高敏感性和特异性,动力学测定法似乎对LAL-D筛查具有实用性。
使用荧光底物的总脂肪酶活性动力学测定法可可靠检测导致沃尔曼病和胆固醇酯贮积病的溶酶体酸性脂肪酶缺乏症。